Emeis (WBO:ORP2) Short Ratio


WBO:ORP2 Emeis WBO:ORP2
46 GF Score
Price €13.98
GF Value €9.21
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Emeis Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WBO:ORP2
46GF Score
Emeis WBO:ORP2
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Emeis (WBO:ORP2) Overvalued in 2026?

Based on GuruFocus' analysis, Emeis stock appears to be overvalued. The current stock price of €13.98 is trading 51.8% above its estimated GF Value™ of €9.21. GuruFocus considers Emeis to be Significantly Overvalued.

Key valuation signals for WBO:ORP2:

  • Short Ratio:
  • GF Value™: €9.21 vs. price of €13.98 (51.8% above fair value)
  • GF Score™: 46/100 with 8 warning signs

No single metric tells the full story. See the WBO:ORP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Emeis Business Description

Address 12, Rue Jean Jaures, CS 10032, Puteaux Cedex, Paris, FRA, 92 813
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
46GF Score

Get the complete analysis for WBO:ORP2

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.98
Price
€9.21
GF Value